Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype

Completed · Phase 3 · Has a placebo group

Conditions studied: Asthma

In brief

This is a multi-center, randomized, placebo-controlled, double-blind, parallel group study that aims to assess the efficacy and safety of GSK3511294 (Depemokimab) in participants with severe uncontrolled asthma with an eosinophilic phenotype

Key facts

Study ID

NCT04719832

Run by

GlaxoSmithKline

People needed

395

Starts

2021-03-17

Expected to finish

2023-11-21

Last updated by the study team

2024-12-17

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• GSK Investigational Site — Long Beach, California, United States
• GSK Investigational Site — Pasadena, California, United States
• GSK Investigational Site — Rancho Cucamonga, California, United States
• GSK Investigational Site — San Jose, California, United States
• GSK Investigational Site — Coral Gables, Florida, United States
• GSK Investigational Site — Loxahatchee Groves, Florida, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — New Port Richey, Florida, United States
• GSK Investigational Site — Orlando, Florida, United States
• GSK Investigational Site — Alpharetta, Georgia, United States
• GSK Investigational Site — Calhoun, Georgia, United States
• GSK Investigational Site — Columbus, Georgia, United States
• GSK Investigational Site — Savannah, Georgia, United States
• GSK Investigational Site — Normal, Illinois, United States
• GSK Investigational Site — Lexington, Kentucky, United States
• GSK Investigational Site — Owensboro, Kentucky, United States
• GSK Investigational Site — Rochester Hills, Michigan, United States
• GSK Investigational Site — Las Vegas, Nevada, United States
• GSK Investigational Site — New York, New York, United States
• GSK Investigational Site — The Bronx, New York, United States
• GSK Investigational Site — Gastonia, North Carolina, United States
• GSK Investigational Site — Cleveland, Ohio, United States
• GSK Investigational Site — Boerne, Texas, United States
• GSK Investigational Site — Encinitas, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.